SEQUENOM INC. NEW läuft weiter megamässsig!!

..jeiha  

http://www.sequenom.com/invest/corporate-governance GrB  

Dschorannimo iss RAUS ..unddd BASTA ..ha

Kosmonova buran  

board@sequenom.com
http://www.sequenom.com/invest/corporate-governance  

..so buran?  

..übel übel riech

Kosmonova buran  

http://www.sequenom.com/invest/analyst-coverage GrB  

http://www.sequenom.com/invest/stock-information GrB  

..yöah  

http://www.sequenom.com/invest/stock-information GrB  

http://www.sequenom.com/invest/stock-information GrB
 

..yöah  

http://www.sequenom.com/invest/sec-filings GrB  

..yöah  

http://www.sequenom.com/invest/financial-reports GrB  

http://www.sequenom.com/invest/financial-reports GrB
 

..yöah  

bhoa...  

http://www.sequenom.com/invest/fundamentals GrB  

http://www.sequenom.com/press GrB  

ILLUMINA AND SEQUENOM POOL NONINVASIVE PRENATAL TESTING INTELLECTUAL PROPERTY AND END OUTSTANDING PATENT DISPUTES http://www.sequenom.com/press/...esting-intellectual-property-and-end
 

..yöah  

..juha  

worldwide rights to utilize the pooled intellectual property to develop and sell in-vitro diagnostic kits for NIPT and to license third-party laboratories wishing to develop and sell their own laboratory-developed NIPT tests under the collection of pooled patents. In addition, Sequenom and Illumina will each have rights to utilize all pooled patents to develop and sell their own respective laboratory-developed NIPT tests. The parties will share the revenue from the patent pool and Illumina will pay Sequenom a royalty on sales of in-vitro diagnostic kits for NIPT. http://www.sequenom.com/press/...esting-intellectual-property-and-end
 

man man Dschorannimo

Kosmonova buran